Private Equity and Venture Capital Investment in the Global Pharmaceutical and Biotechnology Industry
Private Equity and Venture Capital Investment in the Global Pharmaceutical and Biotechnology Industry
Vigilance and Equanimity are the Needs of the Hour
12-Feb-2014
Asia Pacific
Description
This study for the private equity and venture capital trends in the global pharmaceutical and biotechnology industry analyzes the various deals in the industry. The deals are analyzed based on number and average value. The trends are also observed based on the geographic region and buyer types. The study delves into the nature of cross border deals and also keeps into account various deal multiples such as deal value and investment rounds. The distribution of deals across key therapeutic areas has been dealt to understand the focus of investors and to highlight the key therapeutic areas in the near future. The analysis also includes geography-wise interest of buyers in regions across other geographies in terms both deal value and volume.
Table of Contents
Executive Summary
Key Terms Used in the Study
Key Terms Used in the Study (continued)
Objectives of the Study
Research Objective and Scope
Research Objective and Scope (continued)
Research Methodology
Pharma and Biotech Industry—Stock Indices Performance
Reducing Profitability
Regulatory Challenges
Patent Expiry
Changing Role of Big Pharma
Overall HC Industry—PEVC Deal Trends by Volume
PEVC Deal Trends by Volume and Value
PEVC Deal Trends by Average Deal Value by Transaction Type
Volume and Value of PE Deal Trends by Sectors
PEVC Deals Involving Big Pharma
VC Deal Trends by Sectors
Pharmaceutical Sector—Stages of VC Investment Snapshot
Pharmaceutical Sector—Stages of VC Investment Average Deal Value Analysis
Biotechnology Sector—Stages of VC Investment Snapshot
Biotechnology Sector—Stages of Financing Deal Value Analysis
Deal Value Range Analysis—VC Investment
Deal Value Range Analysis—PE Investment
PEVC Deal Analysis Across Geographies
PEVC Deal Share Analysis Across Geographies
PEVC Deal Analysis in the North American Region
PEVC Deal Snapshot in the North American Region
PEVC Deal Analysis in the European Region
PEVC Deal Snapshot in European Region
PEVC Deal Analysis in the APAC Region
PEVC Deal Snapshot in APAC Region
Volume Analysis of IPO
Value Analysis of IPO
Value Analysis of IPO by Geography
PEVC Volume Analysis by Key Therapeutic Areas
PEVC Value Analysis by Key Therapeutic Areas
Five Big Conclusions
Legal Disclaimer
Who is Frost & Sullivan
What Makes Us Unique
TEAM Methodology
Our Global Footprint 40+ Offices
Related Research
No Index | Yes |
---|---|
Podcast | No |
Author | Saneesh Edacherian |
WIP Number | ND74-01-00-00-00 |
Is Prebook | No |